New data from 2024–2025 show how polygenic risk scores may refine prostate cancer screening and risk stratification, improving early detection while raising important clinical and ethical challenges.
EAU SRH 2025 updates strengthen ED management with structured diagnosis, better PDE5 strategies and clarified testosterone use, highlighting ED as a key indicator of men’s health.
The holiday season brings heavier workloads, reduced staffing and emotional strain. For many clinicians, Christmas is not a break but an amplifier of burnout risk.
After two years in Bangladesh, a 35-year-old woman returns with fever, upper abdominal pain and weakness. Can you diagnose her condition?
Who benefits most from fruquintinib in metastatic colorectal cancer? A subgroup analysis of the FRESCO-2 study focuses on individuals with long overall survival.
A 54-year-old woman has back pain and a long-neglected breast lump. Her clinical journey will require more than a single decision, challenging the tumor board to choose the right steps at the right time.
Achalasia patients have higher risk of oesophageal cancer. A new study identifies oesophageal Candida infections as a possible cancer development risk factor.
Breast-cancer screening is entering a new phase. Mammography stays the cornerstone, while AI and MRI in dense breasts accelerate the move toward personalized screening.
From Halsted’s radical mastectomy to precision oncology, breast cancer treatments garnered science, suffering and progress, revealing how medicine learned to heal without dehumanizing.
New SRY-gene screenings by World Athletics for female athlete eligibility reopens a sensitive debate overlapping genetics, endocrinology, and ethics.
HER2-low has reshaped treatment strategy in HR-positive disease. DESTINY-Breast06 confirms that ADCs deserve an earlier role after CDK4/6 inhibition.
A teenager arrives at the ED with confusion and visual hallucinations. Negative labs and imaging complicate the search for the underlying cause.
A pilot study shows significant differences in the gut microbiome between anxious and non-anxious individuals.
It is well known that GLP-1 receptor agonists have a cardioprotective effect in type 2 diabetes. But little is known about their cardiovascular safety in combination.
SBRT can be used for different categories of oligometastatic disease. The disease covers a broad spectrum. A summary of its manifestations and treatment.
Over the past two years, significant progress has been made in cancer treatment with RNA-based vaccines. Some researchers see this as the beginning of a new era in oncology.
Social media and AI are key components of modern dermatology practices. Can they improve doctor-patient communication and daily work?
An international study shows that atopic dermatitis increases the risk of suicidal thoughts. Holistic approaches required. An interview with Dr Delphine Kerob.
News about the skin-gut-brain axis: Innovative findings on disease mechanisms promise advances in diagnosis and therapy.
New research findings on atypical forms of syphilis and innovative treatment strategies offer valuable insights for clinical practice.